Compare LAKE & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAKE | SNN |
|---|---|---|
| Founded | 1982 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.3M | 14.0B |
| IPO Year | 1986 | 1999 |
| Metric | LAKE | SNN |
|---|---|---|
| Price | $8.00 | $33.07 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 4 |
| Target Price | $17.33 | ★ $32.83 |
| AVG Volume (30 Days) | 428.5K | ★ 496.7K |
| Earning Date | 12-09-2025 | 03-02-2026 |
| Dividend Yield | 1.51% | ★ 2.23% |
| EPS Growth | N/A | ★ 59.91 |
| EPS | N/A | ★ 0.56 |
| Revenue | $193,456,000.00 | ★ $5,944,000,000.00 |
| Revenue This Year | $29.73 | $7.78 |
| Revenue Next Year | $8.45 | $5.13 |
| P/E Ratio | ★ N/A | $58.80 |
| Revenue Growth | ★ 27.42 | 5.35 |
| 52 Week Low | $7.77 | $23.69 |
| 52 Week High | $27.28 | $38.79 |
| Indicator | LAKE | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 19.81 | 49.26 |
| Support Level | $7.77 | $32.66 |
| Resistance Level | $8.44 | $33.60 |
| Average True Range (ATR) | 0.63 | 0.42 |
| MACD | -0.45 | 0.10 |
| Stochastic Oscillator | 3.96 | 56.76 |
Lakeland Industries Inc manufactures and sells safety garments and accessories for the industrial protective clothing market. Its product segments include Disposables, Chemicals, Fire, Gloves, High Visibility, High-Performance Wear, and Wovens. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, and mortuaries, as well as scientific and medical laboratories. Its geographical segments include the United States, Latin America, Canada, Asia, Mexico, Europe (United Kingdom), and Other Foreign.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.